Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
← catalyst calendarNCT07144319 · readout ≤ 499 d
Sponsored by Photocure (industry) · PHO.OL — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
500estimated
Sites
5
Countries
Belgium, Norway, United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-03-25 | actual | When the study began enrolling |
| Primary completion | Dec 2027 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2027 | estimated | The whole study's end, after follow-up |
| First posted | 2025-08-27 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-14 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Bladder Cancer
- Non-muscle Invasive Bladder Cancer
Primary outcome
what the primary-completion date above is the date OFVideo and image collection
measured 1 day
Permalink · PHO.OL's whole pipeline · Catalyst calendar · Every registered study · What changed